Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)Business Wire • 12/14/23
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual MeetingBusiness Wire • 10/31/23
Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023Business Wire • 10/11/23
Compared to Estimates, Glaukos (GKOS) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/03/23
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.Business Wire • 07/17/23
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023Business Wire • 07/12/23
Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)Business Wire • 06/05/23